CAGRI 5MG
$50.00 $35.0030% OFF
Cagri 5mg
Long-acting amylin analogue studied for satiety signaling, gastric modulation, and metabolic pathway regulation in controlled research environments.
- 5mg lyophilized peptide
- Amylin receptor pathway research
- Metabolic regulation studies
- For research use only
Out of stock
Cagri 5mg
Long-acting amylin analogue studied for metabolic regulation, satiety signaling, and glucose-control pathway research.
Compound Overview
Cagri (Cagrilintide) is a synthetic, long-acting analogue of amylin, a peptide hormone co-secreted with insulin from pancreatic beta cells. Amylin is involved in postprandial glucose regulation, gastric emptying modulation, and appetite signaling within metabolic pathways.
In research environments, Cagri is studied for its interaction with amylin receptors and downstream signaling cascades influencing satiety response, energy balance, and glucose homeostasis. Long-acting amylin analogues are frequently evaluated in controlled laboratory models examining metabolic regulation and peptide-based endocrine signaling systems.
Receptor Activity
Targets amylin receptors involved in appetite regulation, gastric motility modulation, and glucose-control signaling pathways.
Research Focus Areas
Commonly examined in metabolic research models evaluating energy balance, insulin-glucagon interplay, and endocrine pathway interactions.
Laboratory Classification
Classified as a synthetic amylin analogue for experimental and analytical research applications.
Product Specifications
- Product Name: Cagri (Cagrilintide)
- Peptide Type: Long-acting amylin analogue
- Quantity: 5mg per vial
- Form: Lyophilized peptide powder
- Intended Use: Research use only
Be the first to review “CAGRI 5MG”
Related products
Reviews
There are no reviews yet.